These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6183617)

  • 21. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.
    Böcher WO; Galun E; Marcus H; Daudi N; Terkieltaub D; Shouval D; Löhr HF; Reisner Y
    Hepatology; 2000 Feb; 31(2):480-7. PubMed ID: 10655274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Prevention of hepatitis B with "immune" globulin.
    N Engl J Med; 1976 Mar; 294(10):553-6. PubMed ID: 55968
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
    Urbanowicz W
    Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus markers among family contacts and medical personnel of 239 hemodialysis patients.
    Gahl GM; Vogl E; Kraft D; Hess G; Arnold W
    Clin Nephrol; 1980 Jul; 14(1):8-12. PubMed ID: 7408256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B immune globulin (human).
    Med Lett Drugs Ther; 1978 Jan; 20(2):9-10. PubMed ID: 74011
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of HAA-positive hepatitis with serum gamma globulin.
    Conrad ME
    N Engl J Med; 1971 Dec; 285(26):1486-7. PubMed ID: 4107820
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoprevention of hepatitis B in children of HBsAg-positive pregnant patients].
    Fengler JD; Baumgarten R; Markus R; Fischer J; Löschner J; Schwanke H; Küllertz G
    Z Gesamte Inn Med; 1984 Jul; 39(14):326-30. PubMed ID: 6485431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal dialysis is the better therapy choice for successful anti-hepatitis B vaccination.
    Svác J; Skladaný L; Sekerková Z; Javorský P; Leskova L; Mizla P; Jankechová I; Pasminka T
    Adv Perit Dial; 2005; 21():151-3. PubMed ID: 16686308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult hepatitis B virus infection in a North American adult hemodialysis patient population.
    Minuk GY; Sun DF; Greenberg R; Zhang M; Hawkins K; Uhanova J; Gutkin A; Bernstein K; Giulivi A; Osiowy C
    Hepatology; 2004 Nov; 40(5):1072-7. PubMed ID: 15486926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of hepatitis with gamma globulin.
    Lemon SM; Gates N; Bancroft WH
    Ann Intern Med; 1980 Jun; 92(6):869-70. PubMed ID: 6155817
    [No Abstract]   [Full Text] [Related]  

  • 40. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.